Full Press Release Details
THOUSAND OAKS, Calif. , Dec. 5, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate at the Oppenheimer 24 th Annual Healthcare Conference on Tuesday, Dec. 10, 2013 , at the Crowne Plaza in New York City , beginning at 9:45 a.m. Eastern Standard Time . Arvind Sood , vice president of Investor Relations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors. A replay of the webcast will also be available on Amgen's website for 90 days following the event.
About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
CONTACT: Amgen, Thousand Oaks Ashleigh Koss , 805-313-6151 (media) Arvind Sood , 805-447-1060 (investors)